PLTR
Palantir Technologies Inc.Close $146.39EOD onlyThis page reflects PLTR options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.
Historical consensus-supported lens with full content, report chain context, and metric rail.
You are viewing an older report from April 10, 2026. A newer directional report is available for April 17, 2026.
View latest reportOutlook
Neutral-to-bearish short-term with downside pressure toward the gamma flip near $120 but larger-term directional edge to the upside toward the cluster at $140–$155 limited by large call OI; Confidence: 6.0/10.
Conflicts: IV term bump 67.2% at 28d (raises cost of buying premium), 7–14d ATM IV ~56% (cheaper short-dated premium), P/C OI ~1.04 (put interest intact).
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $-40.3M
DEX: +88.5M shares
Gamma flip: ~$120 (Approx — based on put OI concentration of 20,845 (6.3% below spot))
NTM gamma: Near-term negative gamma concentrated below spot; dealers short gamma — if spot drops 2% (~$125.50) dealers will buy stock to hedge puts which can mechanically reduce selling but add later unwind risk; if spot rises 2% (~$130.62) dealers will sell stock to hedge calls, increasing cap pressure near $135–$140.
IV Analysis
IV vs VIX: Avg IV 67.2% — rich vs broad market norms; near-term 7–14d IV ~56% is cheaper than 28d+ (67%).
Term structure: Term shows a 28–35d IV spike (67.2% on 5/08 and 66.3% on 5/15) — likely event/roll pricing with higher mid-term vol; front 7–21d IV sits ~56% (sale/tactical window).
Skew: Notable: 7–14d ATM ~56% vs 28d+ ~67% = ~11 vol-pt differential; calendar/diagonal where you SELL the higher-IV leg (28–35d) is favorable per rule: sell 5/08 IV 67.2 buy 4/17 IV 56.0 → +11.2pt edge.
Flow Analysis
Net premium: Net premium -$118.8M (institutional net buying of calls / sellers receiving negative premium flows implies directional buying pressure).
Directional prints: 59.3 call 125 ITM 2026-04-17 — Large volume 10,185 vs OI 1,030 — aggressive call buys or spreads into 4/17; could be directional long or call-rotate; consistent with short-dated call demand. 56.8 call 130 OTM 2026-04-17 — Massive vol 51,081 OI 5,883 — heavy buy-side/rolls into 4/17 calls; aligns with net call premium in top flow list.
Unusual: 59.4 call 125 ITM 2026-04-24 — PLTR260424C125 large vol 4,062 vs OI 177 (22.9x) — repeated activity in 125 strikes across expiries suggests intentional directional exposure or calendar structuring.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Long stock | Moderate-Weak | Buy shares at market $128.06 | Gamma negative regime can make owning shares choppy; requires conviction to hold through IV spikes. |
| Short stock | Moderate | Short shares around $135 resistance | Short squeeze risk into $140–$155 call wall; dealers selling into rallies increases slippage. |
| Covered call | Moderate | Buy stock + sell 2026-05-08 $140 call (sell higher-IV mid-term) | Call OI cap plus assignment if rally; IV mid-term elevated reduces premium efficiency. |
| Cash-secured put / put spread | Moderate-Strong | Sell 2026-05-22 $120 cash-secured put or sell $120/$110 put spread 2026-05-22 | Gamma flip near $120 — short puts need active management if price approaches flip. |
| Long calls | Moderate-Weak | Buy 2026-05-08 $140 call (high IV) only as directional punt | Mid-term IV elevated (67.2%) makes long calls expensive; premium decay and vol crush risk post-earnings. |
| Long puts / bear put spread | Moderate-Strong | Buy 2026-05-08 $130/$120 bear put spread | Costly due to elevated mid-term IV but aligns with negative GEX trend; max loss limited to debit paid. |
| Iron condor | Moderate-Weak | Sell 2026-04-24 125/120 put x 145/150 call condor | High IV mid-term reduces credit and increases assignment risk; trending negative GEX may break wings. |
| Calendar / diagonal | Moderate-Strong | Sell near-term 2026-04-17 $130 call (IV 56.8) buy 2026-05-08 $130 call (IV 67.2) — reverse per rule: SELL higher-IV leg so actually SELL 5/08 130 buy 4/17 130 (sell higher-IV) | Requires correct identification of higher-IV leg; term skew favorable but needs management on directional moves. |
| PMCC / LEAPS diagonal | Moderate | Buy stock + sell 2026-07-17 $155 call (long-dated) as yield overlay | Call OI wall at $155 may cap; long capital at risk and mid-term IV variability can make rolling costly. |
Top Plays
Watchlist Triggers
Tactical Summary
Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.
Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.
These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.